Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results

TUCSON, Ariz., Jan. 10, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections, today announced certain preliminary, unaudited results for the quarter and year ended December 31, 2024."During the fourth quarter, we continued our momentum across our innovation pipeline with significant progress of the clinical trial ...